Digital Microfluidic Hemagglutination Assays for Blood Typing, Donor Compatibility Testing, and Hematocrit Analysis
© American Association for Clinical Chemistry 2021. All rights reserved. For permissions, please email: journals.permissionsoup.com..
BACKGROUND: Blood typing, donor compatibility testing, and hematocrit analysis are common tests that are important in many clinical applications, including those found in high-stakes settings such as the trauma center. These tests are typically performed in centralized laboratories with sample batching; the minutes that are lost in this mode can lead to adverse outcomes, especially for critical-care patients. As a step toward providing rapid results at the bedside, we developed a point-of-care hemagglutination system relying on digital microfluidics (DMF) and a unique, automated readout tool, droplet agglutination assessment using digital microfluidics (DAAD).
METHODS: ABO and Rhesus blood grouping, donor crossmatching, and hematocrit assays were developed on a portable DMF platform that allowed for automated sample processing. The result of each assay could be determined by eye or automatically with the DAAD imaging tool.
RESULTS: DMF-DAAD was applied to 109 samples collected from different sources (including commercial samples, pinpricks from volunteers, and a hospital blood bank), with perfect fidelity to gold-standard results. Some of these tests were carried out by a nonexpert in a hospital trauma center. Proof-of-concept results were also collected from smaller sample sets for donor compatibility testing and hematocrit analysis.
CONCLUSION: DMF-DAAD shows promise for delivering rapid, reliable results in a format well suited for a trauma center and other settings where every minute counts.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:67 |
---|---|
Enthalten in: |
Clinical chemistry - 67(2021), 12 vom: 26. Nov., Seite 1699-1708 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sklavounos, Alexandros A [VerfasserIn] |
---|
Links: |
---|
Themen: |
Instrumentation |
---|
Anmerkungen: |
Date Completed 13.04.2022 Date Revised 13.04.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/clinchem/hvab180 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM331222930 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM331222930 | ||
003 | DE-627 | ||
005 | 20231225213005.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/clinchem/hvab180 |2 doi | |
028 | 5 | 2 | |a pubmed24n1104.xml |
035 | |a (DE-627)NLM331222930 | ||
035 | |a (NLM)34580703 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sklavounos, Alexandros A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Digital Microfluidic Hemagglutination Assays for Blood Typing, Donor Compatibility Testing, and Hematocrit Analysis |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.04.2022 | ||
500 | |a Date Revised 13.04.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © American Association for Clinical Chemistry 2021. All rights reserved. For permissions, please email: journals.permissionsoup.com. | ||
520 | |a BACKGROUND: Blood typing, donor compatibility testing, and hematocrit analysis are common tests that are important in many clinical applications, including those found in high-stakes settings such as the trauma center. These tests are typically performed in centralized laboratories with sample batching; the minutes that are lost in this mode can lead to adverse outcomes, especially for critical-care patients. As a step toward providing rapid results at the bedside, we developed a point-of-care hemagglutination system relying on digital microfluidics (DMF) and a unique, automated readout tool, droplet agglutination assessment using digital microfluidics (DAAD) | ||
520 | |a METHODS: ABO and Rhesus blood grouping, donor crossmatching, and hematocrit assays were developed on a portable DMF platform that allowed for automated sample processing. The result of each assay could be determined by eye or automatically with the DAAD imaging tool | ||
520 | |a RESULTS: DMF-DAAD was applied to 109 samples collected from different sources (including commercial samples, pinpricks from volunteers, and a hospital blood bank), with perfect fidelity to gold-standard results. Some of these tests were carried out by a nonexpert in a hospital trauma center. Proof-of-concept results were also collected from smaller sample sets for donor compatibility testing and hematocrit analysis | ||
520 | |a CONCLUSION: DMF-DAAD shows promise for delivering rapid, reliable results in a format well suited for a trauma center and other settings where every minute counts | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a instrumentation | |
650 | 4 | |a laboratory methods and tools | |
650 | 4 | |a point-of-care testing systems | |
700 | 1 | |a Lamanna, Julian |e verfasserin |4 aut | |
700 | 1 | |a Modi, Dimpy |e verfasserin |4 aut | |
700 | 1 | |a Gupta, Sidharth |e verfasserin |4 aut | |
700 | 1 | |a Mariakakis, Alex |e verfasserin |4 aut | |
700 | 1 | |a Callum, Jeannie |e verfasserin |4 aut | |
700 | 1 | |a Wheeler, Aaron R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical chemistry |d 1955 |g 67(2021), 12 vom: 26. Nov., Seite 1699-1708 |w (DE-627)NLM000002003 |x 1530-8561 |7 nnns |
773 | 1 | 8 | |g volume:67 |g year:2021 |g number:12 |g day:26 |g month:11 |g pages:1699-1708 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/clinchem/hvab180 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 67 |j 2021 |e 12 |b 26 |c 11 |h 1699-1708 |